Skip to main content
. 2014 Apr 22;110(10):2434–2440. doi: 10.1038/bjc.2014.195

Table 4. Number of patients with AEs grade 3 or 4 in >5% of patients in schedules A and B combined irrespective of relatedness: schedule B (all doses).

 
50 (n=4)
100 (n=4)
150 (n=16)
200 (n=3)
Total (n=27)
Schedule B (mg) n (%) Grade 3 Grade 4 Grade 3 Grade 4 Grade 3 Grade 4 Grade 3 Grade 4 Grade 3 Grade 4
Anaemia
1



1
2
2

4 (14.8)
2 (7.4)
Neutropenia




2
1

2
2 (7.4)
3 (11.1)
Leukopenia




1


1
1 (3.7)
1 (3.7)
Abdominal pain




2



2 (7.4)

Thrombocytopenia






2

2 (7.4)

Fatigue




1

1

2 (7.4)

Pain




2



2 (7.4)

Hypokalaemia


1



1

2 (7.4)

Upper GI haemorrhage




1

1

2 (7.4)

Infection
1





1

2 (7.4)

Ileus






2

2 (7.4)

Dyspnoea


1





1 (3.7)

Vomiting




1



1 (3.7)

Decreased appetite






1

1 (3.7)

Rash




1



1 (3.7)

Abdominal distension






1

1 (3.7)

Dizziness




1



1 (3.7)

Febrile neutropenia 1 1 (3.7)

Abbreviations: AEs=adverse events; GI=gastrointestinal.